Qualitative interview study of patient-reported symptoms, impacts and treatment goals of patients with obstructive hypertrophic cardiomyopathy
Patients with oHCM experience a high symptom burden and psychosocial impacts, affecting health status. Improved shortness of breath, fatigue and physical functioning are highly valued by patients and represent important treatment goals.
Authors
- Supriya Shore (ORCID: https://orcid.org/0000-0002-5436-6097)
- Sheri Fehnel (ORCID: https://orcid.org/0000-0001-8568-0102)
- Stephen B. Heitner (ORCID: https://orcid.org/0000-0003-2189-1474)
- Katherine Kosa (ORCID: https://orcid.org/0000-0002-6461-527X)
- Sara Saberi (ORCID: https://orcid.org/0000-0003-4473-6725)
- Lisa Salberg (ORCID: https://orcid.org/0000-0002-5727-7858)
- Daniel Jacoby (ORCID: https://orcid.org/0000-0002-9182-275X)
- Michael Butzner (ORCID: https://orcid.org/0000-0002-6015-7910)
- Claire Ervin
Institutions
- University of Michigan (US)
- Pulmonary Hypertension Association (US)
- RTI Health Solutions (US)
- Cytokinetics (United States) (US)
Publication Details
- Journal
- BMJ Open
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1136/bmjopen-2023-081323
- Citations
- 2
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- American Heart Association
- Bristol-Myers Squibb
- Cytokinetics
- Actelion Pharmaceuticals